64 related articles for article (PubMed ID: 24980758)
1. Impact of combinations of EGF, TGFβ, 17β-oestradiol, and inhibitors of corresponding pathways on proliferation of breast cancer cell lines.
Mints M; Souchelnytskyi S
Exp Oncol; 2014 Jun; 36(2):67-71. PubMed ID: 24980758
[TBL] [Abstract][Full Text] [Related]
2. Exposure to EGF and 17β‑estradiol irreversibly affects the proliferation and transformation of MCF7 cells but is not sufficient to promote tumor growth in a xenograft mouse model upon withdrawal of exposure.
Cunha SI; Jia M; Souchelnytskyi S
Int J Mol Med; 2018 Sep; 42(3):1615-1624. PubMed ID: 29956719
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of breast cancer metastases by a novel inhibitor of TGFβ receptor 1.
Fang Y; Chen Y; Yu L; Zheng C; Qi Y; Li Z; Yang Z; Zhang Y; Shi T; Luo J; Liu M
J Natl Cancer Inst; 2013 Jan; 105(1):47-58. PubMed ID: 23178439
[TBL] [Abstract][Full Text] [Related]
4. H-ras dependent estrogenic effects of epidermal growth factor in the estrogen-independent breast cancer cell line MDA-MB-231.
Treeck O; Weber A; Boester M; Porz S; Frey N; Diedrich K; Ortmann O
Breast Cancer Res Treat; 2003 Jul; 80(2):155-62. PubMed ID: 12908818
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
Hu M; Wang J; Chen P; Reilly RM
Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
[TBL] [Abstract][Full Text] [Related]
6. Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines.
Cursons J; Leuchowius KJ; Waltham M; Tomaskovic-Crook E; Foroutan M; Bracken CP; Redfern A; Crampin EJ; Street I; Davis MJ; Thompson EW
Cell Commun Signal; 2015 May; 13():26. PubMed ID: 25975820
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
[TBL] [Abstract][Full Text] [Related]
8. Growth of MDA-MB-231 cell line: different effects of TGF-beta(1), EGF and estradiol depending on the length of exposure.
Mur C; Martínez-Carpio PA; Fernández-Montolí ME; Ramon JM; Rosel P; Navarro MA
Cell Biol Int; 1998; 22(9-10):679-84. PubMed ID: 10452838
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the global gene expression profiles produced by methylparaben, n-butylparaben and 17beta-oestradiol in MCF7 human breast cancer cells.
Pugazhendhi D; Sadler AJ; Darbre PD
J Appl Toxicol; 2007; 27(1):67-77. PubMed ID: 17121429
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines.
Zugmaier G; Ennis BW; Deschauer B; Katz D; Knabbe C; Wilding G; Daly P; Lippman ME; Dickson RB
J Cell Physiol; 1989 Nov; 141(2):353-61. PubMed ID: 2808542
[TBL] [Abstract][Full Text] [Related]
11. Effect of estrogen, tamoxifen and epidermal growth factor on the transcriptional regulation of vascular endothelial growth factor in breast cancer cells.
Lee JE; Chung KW; Han W; Kim SW; Kim SW; Shin HJ; Bae JY; Noh DY
Anticancer Res; 2004; 24(6):3961-4. PubMed ID: 15736439
[TBL] [Abstract][Full Text] [Related]
12. Paradoxical regulation of Bcl-2 family proteins by 17beta-oestradiol in human breast cancer cells MCF-7.
Leung LK; Wang TT
Br J Cancer; 1999 Oct; 81(3):387-92. PubMed ID: 10507761
[TBL] [Abstract][Full Text] [Related]
13. Involvement of p21Waf1 in mediating inhibition of paclitaxel-induced apoptosis by epidermal growth factor in MDA-MB-468 human breast cancer cells.
Fang M; Liu B; Schmidt M; Lu Y; Mendelsohn J; Fan Z
Anticancer Res; 2000; 20(1A):103-11. PubMed ID: 10769641
[TBL] [Abstract][Full Text] [Related]
14. [The nuclear factor kappa B activation: the key step of cell proliferation in estrogen receptor-negative breast cancer cells].
Wang HJ; Wu ZY; Fan P; Bian JM
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):1014-6. PubMed ID: 16194364
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic activity of epidermal growth factor-genistein against breast cancer cells.
Uckun FM; Narla RK; Jun X; Zeren T; Venkatachalam T; Waddick KG; Rostostev A; Myers DE
Clin Cancer Res; 1998 Apr; 4(4):901-12. PubMed ID: 9563884
[TBL] [Abstract][Full Text] [Related]
16. AZD3409 inhibits the growth of breast cancer cells with intrinsic resistance to the EGFR tyrosine kinase inhibitor gefitinib.
Maiello MR; D'Alessio A; De Luca A; Carotenuto A; Rachiglio AM; Napolitano M; Cito L; Guzzo A; Normanno N
Breast Cancer Res Treat; 2007 May; 102(3):275-82. PubMed ID: 17004112
[TBL] [Abstract][Full Text] [Related]
17. Theanaphthoquinone inhibits fatty acid synthase expression in EGF-stimulated human breast cancer cells via the regulation of EGFR/ErbB-2 signaling.
Weng MS; Ho CT; Ho YS; Lin JK
Toxicol Appl Pharmacol; 2007 Jan; 218(2):107-18. PubMed ID: 17182072
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.
Hiraga T; Myoui A; Choi ME; Yoshikawa H; Yoneda T
Cancer Res; 2006 Feb; 66(4):2067-73. PubMed ID: 16489006
[TBL] [Abstract][Full Text] [Related]
19. Mammalian sterile-like 1 kinase inhibits TGFβ and EGF‑dependent regulation of invasiveness, migration and proliferation of HEC-1-A endometrial cancer cells.
Attarha S; Andersson S; Mints M; Souchelnytskyi S
Int J Oncol; 2014 Aug; 45(2):853-60. PubMed ID: 24841766
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of EGF gradient profiles on MDA-MB-231 breast cancer cell chemotaxis.
Wang SJ; Saadi W; Lin F; Minh-Canh Nguyen C; Li Jeon N
Exp Cell Res; 2004 Oct; 300(1):180-9. PubMed ID: 15383325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
